Pipeline Embolization for Intracranial Aneurysms
Condition(s) studied
Investigational drug(s) / intervention(s)
Pipeline embolization device with or without shield technique: The patients undenwent Pipeline embolization device implantation with or without shield technique due to market availability, choice and preferences of the surgeon.
Study summary
This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.
Eligibility
Primary outcome measure(s)
- The occlusion rate of the aneurysm — 1 years
The occlusion rate of the aneurysm at 6 months;O'Kelly Marotta classification: complete occlusion (D, entirely non-filling), near-complete occlusion (C, only entry remnant), and incomplete occlusion (A and B, subtotal and total filling).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zhujiang hospital | Guangzhou | Guangdong | Recruiting |
More Zhujiang Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06446778 on ClinicalTrials.gov ↗ ← All trials in China